semaglutide and blindness Can Semaglutides (Ozempic) Cause Blindness? A recent study hints at a potential link between use an increased risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION) Active Ingredient in Ozempic Linked

TGF- is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells

11.0mg 12x/day for a 28 week cycle, 1x/year Administration Route: Subcutaneous injection FOXO4-DRI FOXO4-DRI (D-retro inversion isoform) is a cell-penetrating peptide thats been shown in mice to selectively cause destruction, or induce apoptosis, of senescent cells

Antioxid Redox Signal (2018) 29:1792807

MHRA approves first dual GIP and GLP-1 receptor agonist Mounjaro (tirzepatide) for weight management

Cardio Considerations The enhanced metabolic effects of Retatrutide reduce the need for excessive cardiovascular training to maintain body composition

Presentation 1: A 12-week Trial of MET-097iA Potent and Ultra-long Acting GLP-1 Receptor Agonist Trial Design Metsera conducted a randomized, double-blind, placebo-controlled Phase I/II study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of MET-097ia fully biased, ultra-long-acting GLP-1 receptor agonist